Compliance Rate

Compliance Rate 40.0%
Compliant submissions 2
Incompliant submissions 3
Total trials 5

My Organizations' Clinical Trials

Showing 725 of 2418 entries
View as:

Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00677092 Org: User:
Start: 12/31/07 End: 07/31/09 Due: 07/31/10

Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression

Phase: N/A Priority: Normal
NCT ID: NCT01473615 Org: User:
Start: 11/30/11 End: 06/30/14 Due: 06/30/15

A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT01748890 Org: User:
Start: 12/31/09 End: 12/31/12 Due: 12/31/13

Calcium Supplementation for a Healthy Weight-Lite (CaSHeW Lite)

Phase: N/A Priority: Normal
NCT ID: NCT00386672 Org: User:
Start: 05/31/06 End: 12/31/06 Due: 12/31/07

Quantification of Outcome Measures for Mind-body Interventions

Phase: N/A Priority: Normal
NCT ID: NCT01308970 Org: User:
Start: 03/31/11 End: 10/31/15 Due: 10/31/16

Risk Informed Obesity Care Plan Pilot

Phase: N/A Priority: Normal
NCT ID: NCT07028814 Org: User:
Start: 04/01/25 End: 07/31/26 Due: 07/31/27

Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01821729 Org: User:
Start: 07/31/13 End: 09/30/21 Due: 09/30/22

Real-Time Antiretroviral Therapy Adherence Intervention in Uganda

Phase: N/A Priority: Normal
NCT ID: NCT01957865 Org: User:
Start: 09/30/13 End: 06/30/15 Due: 06/30/16

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

Phase: N/A Priority: Normal
NCT ID: NCT04830046 Org: User:
Start: 09/30/21 End: 08/01/22 Due: 08/01/23

High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull

Phase: N/A Priority: Normal
NCT ID: NCT01346124 Org: User:
Start: 12/31/12 End: 03/31/32 Due: 03/31/33

Blood Pressure Self Management for Hypertension & Prehypertension Using an Internet Enabled, Automated Self Management Program

Phase: N/A Priority: Normal
NCT ID: NCT00786162 Org: User:
Start: 04/30/07 End: 12/31/08 Due: 12/31/09

OCT Vibrography for Biomechanical Properties of Tissues

Phase: N/A Priority: Normal
NCT ID: NCT05759780 Org: User:
Start: 08/19/23 End: 08/28/26 Due: 08/28/27

Financial Incentives for Homeless Smokers: A Community-based RCT

Phase: N/A Priority: Normal
NCT ID: NCT04445662 Org: User:
Start: 06/10/21 End: 10/24/24 Due: 10/24/25

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

Phase: N/A Priority: Normal
NCT ID: NCT06561347 Org: User:
Start: 12/31/24 End: 12/01/27 Due: 12/01/28

Studying the Neuronal Basis of Human Social Cognition

Phase: N/A Priority: Normal
NCT ID: NCT05324579 Org: User:
Start: 05/20/22 End: 06/01/26 Due: 06/01/27

Venetoclax + Azacitidine vs. Induction Chemotherapy in AML

Phase: N/A Priority: Normal
NCT ID: NCT04801797 Org: User:
Start: 05/20/21 End: 01/01/28 Due: 01/01/29

Bortezomib Plus Rituximab for EBV+ PTLD

Phase: N/A Priority: Normal
NCT ID: NCT01058239 Org: User:
Start: 11/30/11 End: 11/30/17 Due: 11/30/18

HCV Post-Exposure Prophylaxis for Health Care Workers

Phase: N/A Priority: Normal
NCT ID: NCT03313414 Org: User:
Start: 08/13/19 End: 01/16/20 Due: 01/16/21

Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome

Phase: N/A Priority: Normal
NCT ID: NCT00114127 Org: User:
Start: 06/30/04 End: 07/31/10 Due: 07/31/11

Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)

Phase: N/A Priority: Normal
NCT ID: NCT06716931 Org: User:
Start: 12/01/24 End: 03/01/26 Due: 03/01/27

From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05661903 Org: User:
Start: 06/08/23 End: 08/31/27 Due: 08/31/28

Open Pilot Trial of a Mind-Body Intervention for Patients With Chronic Hip Pain

Phase: N/A Priority: Normal
NCT ID: NCT06820242 Org: User:
Start: 04/04/25 End: 01/31/26 Due: 01/31/27

Growth Hormone Dynamics and Cardiac Steatosis in HIV

Phase: N/A Priority: Normal
NCT ID: NCT03826160 Org: User:
Start: 01/30/19 End: 04/19/22 Due: 04/19/23

Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT01746251 Org: User:
Start: 01/31/13 End: 11/30/21 Due: 11/30/22

2 Phase Use Of Educational Materials In Head And Neck Cancer Center

Phase: N/A Priority: Normal
NCT ID: NCT02204631 Org: User:
Start: 08/12/14 End: 12/22/16 Due: 12/22/17